ORKA vs. QQQ

Last updated Aug 5, 2026

ORKA (Oruka Therapeutics, Inc) is a stock, while QQQ (Invesco QQQ ETF) is Nasdaq-100 fund tracking the NASDAQ-100 Index. Over the past 10 years, ORKA returned -12.05%/yr vs 20.86%/yr for QQQ. Their 0.24 correlation means their historical movements had little consistent relationship.

Performance

ORKA vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oruka Therapeutics, Inc (ORKA) and Invesco QQQ ETF (QQQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ORKA achieves a 223.75% return, which is significantly higher than QQQ's 18.11% return. Over the past 10 years, ORKA has underperformed QQQ with an annualized return of -12.05%, while QQQ has yielded a comparatively higher 20.86% annualized return.

ORKA

• 1D: 3.52%
• 1M: 15.16%
• 6M: 184.02%
• YTD: 223.75%
• 1Y: 586.22%
• 3Y*: 95.34%
• 5Y*: 37.44%
• 10Y*: -12.05%
• ALL TIME*: -28.16%

QQQ

• 1D: 3.40%
• 1M: 1.58%
• 6M: 17.69%
• YTD: 18.11%
• 1Y: 28.94%
• 3Y*: 25.56%
• 5Y*: 15.07%
• 10Y*: 20.86%
• ALL TIME*: 10.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ORKA Oruka Therapeutics, Inc	$73.53M	$87.90M	$104.72M
QQQ Invesco QQQ ETF	$33.34B	$28.86B	$31.95B

ORKA vs. QQQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ORKA Oruka Therapeutics, Inc	223.75%	56.32%	76.73%	-28.27%	10.23%	-46.38%	-29.77%	-4.88%	-75.30%	-52.63%
QQQ Invesco QQQ ETF	18.11%	20.77%	25.58%	54.86%	-32.58%	27.42%	48.62%	38.96%	-0.13%	32.66%

Correlation

The correlation between ORKA and QQQ is 0.30, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.30
Correlation (3Y) Balances recent behavior with more history.	0.25
Correlation (5Y) Shows whether the relationship held over a longer period.	0.23
Correlation (10Y) Provides a long-term view across more market conditions.	0.17
Correlation (All Time) Calculated using the full available price history since Mar 10, 1999	0.24

The correlation between ORKA and QQQ shifts across timeframes, from 0.17 (10 years) to 0.30 (1 year), reflecting how their relationship changes across market environments.

Return for Risk

ORKA vs. QQQ — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ORKA

ORKA Risk / Return Rank: 99
ORKA Sharpe Ratio Rank: 100
ORKA Sortino Ratio Rank: 99
ORKA Omega Ratio Rank: 98
ORKA Calmar Ratio Rank: 100
ORKA Martin Ratio Rank: 100

QQQ

QQQ Risk / Return Rank: 55
QQQ Sharpe Ratio Rank: 54
QQQ Sortino Ratio Rank: 52
QQQ Omega Ratio Rank: 51
QQQ Calmar Ratio Rank: 62
QQQ Martin Ratio Rank: 58

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ORKA vs. QQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oruka Therapeutics, Inc (ORKA) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ORKA	QQQ	Difference
Sharpe ratio: Return per unit of total volatility	7.58	1.49	+6.09
Sortino ratio: Return per unit of downside risk	5.65	2.07	+3.59
Omega ratio: Gain probability vs. loss probability	1.67	1.26	+0.41
Calmar ratio: Return relative to maximum drawdown	21.13	2.43	+18.70
Martin ratio: Return relative to average drawdown	68.82	7.72	+61.10

ORKA vs. QQQ - Sharpe Ratio Comparison

The current ORKA Sharpe Ratio is 7.58, which is higher than the QQQ Sharpe Ratio of 1.49. The chart below compares the historical Sharpe Ratios of ORKA and QQQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ORKA vs. QQQ - Drawdown Comparison

The maximum ORKA drawdown since its inception was -100.00%, which is greater than QQQ's maximum drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for ORKA and QQQ.

Drawdown Indicators

	ORKA	QQQ	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-82.97%	-17.03%
Max Drawdown (1Y) Largest decline over 1 year	-27.99%	-11.96%	-16.03%
Max Drawdown (3Y) Largest decline over 3 years	-77.76%	-22.77%	-54.99%
Max Drawdown (5Y) Largest decline over 5 years	-77.76%	-35.12%	-42.64%
Max Drawdown (10Y) Largest decline over 10 years	-98.10%	-35.12%	-62.98%
Current Drawdown Current decline from peak	-100.00%	-2.88%	-97.12%
Average Drawdown Average peak-to-trough decline	-93.90%	-32.61%	-61.29%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.58%	3.76%	+4.82%

Volatility

ORKA vs. QQQ - Volatility Comparison

Oruka Therapeutics, Inc (ORKA) has a higher volatility of 18.45% compared to Invesco QQQ ETF (QQQ) at 7.63%. This indicates that ORKA's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ORKA	QQQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.45%	7.63%	+10.82%
Volatility (6M) Calculated over the trailing 6-month period	53.49%	16.43%	+37.06%
Volatility (1Y) Calculated over the trailing 1-year period	78.18%	19.61%	+58.57%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	72.55%	22.97%	+49.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	152.73%	22.54%	+130.19%

Dividends

ORKA vs. QQQ - Dividend Comparison

ORKA has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.42%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ORKA Oruka Therapeutics, Inc	0.00%	0.00%	99.82%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
QQQ Invesco QQQ ETF	0.42%	0.45%	0.56%	0.62%	0.80%	0.43%	0.55%	0.74%	0.91%	0.84%	1.06%	0.99%

Frequently Asked Questions

Can I hold both ORKA and QQQ in my portfolio?

ORKA and QQQ have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ORKA or QQQ?

ORKA has higher volatility (18.45%) compared to QQQ (7.63%). In terms of maximum drawdown, ORKA dropped -100.00% vs QQQ's -82.97%.

Which has better risk-adjusted returns?

ORKA currently has the higher Sharpe Ratio (7.58 vs 1.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.